These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 1739930

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prognostic factors in medulloblastoma, including DNA ploidy.
    Zerbini C, Gelber RD, Weinberg D, Sallan SE, Barnes P, Kupsky W, Scott RM, Tarbell NJ.
    J Clin Oncol; 1993 Apr; 11(4):616-22. PubMed ID: 8478656
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The therapeutic outcome of medulloblastoma in 49 children.
    Jaing TH, Hung IJ, Yang CP, Wang HS, Hung PC.
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995 Apr; 36(4):279-85. PubMed ID: 7572172
    [Abstract] [Full Text] [Related]

  • 9. Local control in non-metastatic medulloblastoma.
    Christopherson KM, Bradley JA, Rotondo RL, Pincus DW, Fort JA, Morris CG, Mendenhall NP, Marcus RB, Indelicato DJ.
    Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
    [Abstract] [Full Text] [Related]

  • 10. Molecular progression of SHH-activated medulloblastomas.
    Korshunov A, Okonechnikov K, Sahm F, Ryzhova M, Stichel D, Sievers P, Meyer J, Schrimpf D, Zheludkova O, Golanov A, Lichter P, Jones DTW, Pfister SM, von Deimling A, Kool M.
    Acta Neuropathol; 2019 Aug; 138(2):327-330. PubMed ID: 31030238
    [No Abstract] [Full Text] [Related]

  • 11. A review of the factors influencing the prognosis of medulloblastoma. The importance of cell differentiation.
    Caputy AJ, McCullough DC, Manz HJ, Patterson K, Hammock MK.
    J Neurosurg; 1987 Jan; 66(1):80-7. PubMed ID: 3783262
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Survival and prognostic factors in a series of adults with medulloblastomas.
    Riffaud L, Saikali S, Leray E, Hamlat A, Haegelen C, Vauleon E, Lesimple T.
    J Neurosurg; 2009 Sep; 111(3):478-87. PubMed ID: 19231932
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The radiation treatment of medulloblastoma.
    Jenkin D.
    J Neurooncol; 1996 Jul; 29(1):45-54. PubMed ID: 8817415
    [Abstract] [Full Text] [Related]

  • 18. Medulloblastoma--prognostic factors and outcome of treatment: review of the Mayo Clinic experience.
    Garton GR, Schomberg PJ, Scheithauer BW, Shaw EG, Ilstrup DM, Blackwell CR, Laws ER, Earle JD.
    Mayo Clin Proc; 1990 Aug; 65(8):1077-86. PubMed ID: 2117687
    [Abstract] [Full Text] [Related]

  • 19. Cerebellar medulloblastomas in adults.
    Tekkök IH, Süzer T, Ozgen T, Erbengi A.
    Neurosurg Rev; 1991 Aug; 14(2):135-40. PubMed ID: 1870719
    [Abstract] [Full Text] [Related]

  • 20. TP53 mutations in favorable-risk Wnt/Wingless-subtype medulloblastomas.
    Lindsey JC, Hill RM, Megahed H, Lusher ME, Schwalbe EC, Cole M, Hogg TL, Gilbertson RJ, Ellison DW, Bailey S, Clifford SC.
    J Clin Oncol; 2011 Apr 20; 29(12):e344-6; author reply e347-8. PubMed ID: 21357788
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.